Can we predict the development of serious adverse events (SAEs) and early treatment termination in elderly non-small cell lung cancer (NSCLC) patients receiving platinum-based chemotherapy?

Toshio Kato, Masahiro Morise, Masahiko Ando, Eiji Kojima, Tomohiko Ogasawara, Ryujiro Suzuki, Joe Shindoh, Masami Matsumoto, Yasuteru Sugino, Masahiro Ogawa, Yasuhiro Nozaki, Tetsunari Hase, Masashi Kondo, Hiroshi Saito, Yoshinori Hasegawa

Research output: Contribution to journalArticlepeer-review

1 Citation (Scopus)

Fingerprint Dive into the research topics of 'Can we predict the development of serious adverse events (SAEs) and early treatment termination in elderly non-small cell lung cancer (NSCLC) patients receiving platinum-based chemotherapy?'. Together they form a unique fingerprint.

Medicine & Life Sciences